Steven D. Rubin

Steven D. Rubin is a declared insider at 6 companies (board member); the most frequent names are Red Violet, Inc., Opko Health, Inc. and Entera Bio Ltd. In total, 17 filings cover trades dated from 24 September 2021 to 7 August 2026.

Market trades split into 5 purchases (€46k) and 1 sale (€356k). Taken together, the sales exceed the purchases by €310k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 10 share grants and 1 option exercise. 2026 to date brings 2 purchases and no sales.

Half of the purchases are above €9,530 and half below. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 7 August 2026 came the latest disclosure, a share grant in Entera Bio Ltd. The last insider purchase was made public on 17 February 2026, 243 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.